Method and compositions for treating Coronavirus infection
Robert A. Newman, Surry, ME (US); Otis C. Addington, San Antonio, TX (US); Jose R. Matos, Plano, TX (US); and Richard J. Obiso, Christiansburg, VA (US)
Assigned to PHOENIX BIOTECHNOLOGY, INC., San Antonio, TX (US)
Filed by PHOENIX BIOTECHNOLOGY, INC., San Antonio, TX (US)
Filed on Dec. 17, 2021, as Appl. No. 17/554,639.
Application 17/554,639 is a continuation in part of application No. 17/473,594, filed on Sep. 13, 2021.
Application 17/473,594 is a continuation in part of application No. PCT/US2021/022800, filed on Mar. 17, 2021.
Application PCT/US2021/022800 is a continuation in part of application No. PCT/US2020/042009, filed on Jul. 14, 2020.
Application PCT/US2020/042009 is a continuation in part of application No. 16/895,920, filed on Jun. 8, 2020, granted, now 10,729,735, issued on Aug. 4, 2020.
Claims priority of provisional application 63/159,242, filed on Mar. 10, 2021.
Claims priority of provisional application 63/051,576, filed on Jul. 14, 2020.
Claims priority of provisional application 63/042,656, filed on Jun. 23, 2020.
Claims priority of provisional application 63/034,800, filed on Jun. 4, 2020.
Claims priority of provisional application 63/029,530, filed on May 24, 2020.
Claims priority of provisional application 63/021,512, filed on May 7, 2020.
Claims priority of provisional application 63/017,263, filed on Apr. 29, 2020.
Claims priority of provisional application 63/014,294, filed on Apr. 23, 2020.
Claims priority of provisional application 63/010,246, filed on Apr. 15, 2020.
Claims priority of provisional application 63/002,735, filed on Mar. 31, 2020.
Prior Publication US 2022/0160741 A1, May 26, 2022
1. A method of preventing SARS-COV-2 infection in a subject in need thereof, the method comprising administering to said subject one or more doses comprising an effective amount of an oleandrin-containing composition.